All data are based on the daily closing price as of February 6, 2026
i
Ildong Pharmaceutical
249420.KO
24.39 USD
-0.92
-3.63%
Overview
Last close
24.39 usd
Market cap
768.33M usd
52 week high
30.05 usd
52 week low
7.11 usd
Target price
34.06 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.9677
Price/Book Value
5.1656
Enterprise Value
881.79M usd
EV/Revenue
2.2489
EV/EBITDA
21.7339
Key financials
Revenue TTM
399.25M usd
Gross Profit TTM
150.79M usd
EBITDA TTM
27.34M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
409.71M usd
Net debt
56.91M usd
About
Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, and urogenital system applications. It also provides raw material drugs; health foods and foods; beverages; cosmetics; medical devices for scar treatment; and other drugs for treating thick wounds, osteoarthritis, periarthritis of shoulder, and artificial tears, as well as feminine cleanser products. The company was founded in 1941 and is headquartered in Seoul, South Korea.